| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.07 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.08 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.08 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.08 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.08 |